Sign-on Bonus: $5,000 Length of Program: April 1st – Sept 30th Payout: 1st payout of $2,500 after month 7; 2nd payout of $2,500 after month 12. Join an elite group of sales professionals bringing customized, white
Who we are Huawei is a leading global provider of information and communications technology (ICT) infrastructure and smart devices, founded in 1987, in the southern Chinese city of Shenzhen. We have more than 213,000 employees and
About Huawei Huawei is a leading global provider of information and communications technology (ICT) infrastructure and smart devices, founded in 1987, in the southern Chinese city of Shenzhen. We have more than 213,000 employees and we
Job summary Identifies, evaluates, develops and closes new customers and expands business at existing customers. Identifies and assists in progressing biopharmaceutical business opportunities including new scientific and strategic partnerships, collaborations, licensing opportunities, joint ventures and alliances.
Your future starts with a move. Make it with the #VFInternshipProgram at our EMEA HQ in Stabio, Switzerland as Go To Market & Sample Management Intern for the VANS Go To Market Department. At VF, shaping
Your future starts with a move. Make it with the #VFInternshipProgram at our EMEA HQ in Stabio, Switzerland as Go To Market & Sample Management Intern for the VANS Go To Market Department. At VF, shaping
Join Horace Mann and Unlock Your Financial Potential Ready to take control of your financial future? At Horace Mann, we are here to support you in achieving your goals and making a meaningful difference in the
At Anaplan, we are a team of innovators focused on optimizing business decision-making through our leading AI-infused scenario planning and analysis platform so our customers can outpace their competition and the market. What unites Anaplanners across
Career Area:Sales Job Description: Your Work Shapes the World at Caterpillar Inc. When you join Caterpillar, youre joining a global team who cares not just about the work we do – but also about each other.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)